Overview

LF

ONC

LOA

SCH

STH

TH

WaSH

Introduction
Drug packages
Coendemicity
JAP search
Cartography

National summary statistics for 2019

Endemic NTDs requiring PC
Lymphatic filariasis
Onchocerciasis
STH
Schistosomiasis
Trachoma
NTDs targeted with PC
Lymphatic filariasis
Onchocerciasis
STH
Trachoma

Demographics

186
Number of implementation units (IUs)
53,217,936
Total Population
6,865,113
Total PreSAC Population
11,923,250
Total SAC Population
29,855,258
Total Adult Population

Programme status*

0people
0IUs
Population living in IUs with endemicity unknown for at least one PC-NTD
31,047,424people
185IUs
Population requiring PC for at least one PC-NTD
22,071,392people
96IUs
Population living in IUs that have stopped PC for at least one PC-NTD

Delivery of PC in 2019*

11,766,467people
134IUs
Population targeted with PC for at least one NTD
11,513,621people
134IUs
Population treated with PC for at least one NTD
0 IUs (<1% of all endemic IUs)
IUs achieving effective coverage for all NTDs requiring PC

Reporting

Most recent approved JRF
2019
Most recent approved JRSM
2021
*These statistics exclude trachoma, as data are currently reporting using alternative implementation unit information, making integration unfeasible

Data source

Unless otherwise stated, all programmatic and epidemiological data underlying these dashboards are provided by countries to ESPEN through WHO reporting processes, including via the PC Joint Application Package. All reasonable precautions have been taken to verify this information.

Lymphatic filariasis

Progress dashboard
Forecast dashboard
Maps
Data

Key statistics for

Please click on an Implementation Unit to view the PC coverage/year

Onchocerciasis

Progress dashboard
Forecast dashboard
Maps
Data

Key statistics for

Population living in IUs requiring PC: 6,476,193 people | 28 IUs
Population living in IUs that have stopped PC: 0 people | 0 IUs
Population targeted for PC: 5,180,954 people | 28 IUs in total
Population treated with PC: 5,342,935 people | 28 IUs in total
28 IUs achieved effective coverage
Drug regimen: ALB+IVM in 1 IUs IVM in 27 IUs
Coverage indicators
Geographic coverage: 100% of endemic IUs covered by PC
Programme coverage: 103% of individuals living in targeted IUs were treated
National coverage: 83% of individuals requiring PC in the country were treated
Please click on an Implementation Unit to view the PC coverage/year